Literature DB >> 30779474

Involvement of PI3K/Akt pathway in the protective effect of hesperidin against a chemically induced liver cancer in rats.

Yomna S Mo'men1, Rasha M Hussein1, Mohamed A Kandeil2.   

Abstract

Hesperidin is a flavanone glycoside that is found in the Citrus species and showed antioxidant, hepatoprotective as well as anticancer activity. This study investigated the effect of hesperidin on the PI3K/Akt pathway as a possible mechanism for its protective effect against diethylnitrosamine (DEN)-induced hepatocellular carcinoma (HCC). Adult Wistar rats were divided into Control group (received drug vehicle); DEN group (received 100 mg/L of DEN solution for 8 weeks), and hesperidin + DEN group (received 200 mg/kg body weight of hesperidin/day orally for 16 weeks + DEN solution as DEN group). Our findings showed that the administration of hesperidin significantly decreased the elevation in liver function enzymes, serum AFP level, and oxidative stress markers. Moreover, hesperidin administration suppressed DEN-induced upregulation of PI3K, Akt, CDK-2 protein expression, and preserved the integrity of the liver tissues from HCC formation. In conclusion, the hepatoprotective activity of hesperidin is mediated via its antioxidation and downregulation of the PI3K/Akt pathway.
© 2019 Wiley Periodicals, Inc.

Entities:  

Keywords:  animal models; antioxidant; cancer prevention; cell signaling; flavonoids

Year:  2019        PMID: 30779474     DOI: 10.1002/jbt.22305

Source DB:  PubMed          Journal:  J Biochem Mol Toxicol        ISSN: 1095-6670            Impact factor:   3.642


  7 in total

Review 1.  Flavonoids from Aurantii Fructus Immaturus and Aurantii Fructus: promising phytomedicines for the treatment of liver diseases.

Authors:  Jianzhi Wu; Guangrui Huang; Yajing Li; Xiaojiaoyang Li
Journal:  Chin Med       Date:  2020-08-26       Impact factor: 5.455

2.  Potential protective effect of hesperidin on hypoxia/reoxygenation-induced hepatocyte injury.

Authors:  Shilai Li; Jijin Zhu; Ling Pan; Peiqi Wan; Quanlin Qin; Daqing Luo; Wenhui Pan; Yuqing Wei; Yansong Xu; Liming Shang; Xinping Ye
Journal:  Exp Ther Med       Date:  2021-05-13       Impact factor: 2.447

3.  Hesperidin ameliorates liver ischemia/reperfusion injury via activation of the Akt pathway.

Authors:  Shilai Li; Quanlin Qin; Daqing Luo; Wenhui Pan; Yuqing Wei; Yansong Xu; Jijin Zhu; Liming Shang
Journal:  Mol Med Rep       Date:  2020-10-06       Impact factor: 2.952

4.  Orange Juice Attenuates Circulating miR-150-5p, miR-25-3p, and miR-451a in Healthy Smokers: A Randomized Crossover Study.

Authors:  Mariana S Dorna; Elizabete M S Barbosa; Matheus A Callegari; Suzana E Tanni; Fernanda Chiuso-Minicucci; Tainara F Felix; Ana L Seneda; Camila R Correa; Ana A H Fernandes; Paula S Azevedo; Bertha F Polegato; Marcelo M Rogero; Sergio A R Paiva; Leonardo A M Zornoff; Patricia P Reis; Marcos F Minicucci
Journal:  Front Nutr       Date:  2021-12-24

5.  Yang-Yin-Jie-Du decoction overcomes gefitinib resistance in non-small cell lung cancer via down-regulation of the PI3K/Akt signalling pathway.

Authors:  Shu-Yi Chen; Gao-Chen-Xi Zhang; Qi-Jin Shu
Journal:  Pharm Biol       Date:  2021-12       Impact factor: 3.503

Review 6.  Peroxisome proliferator-activated receptor gamma as a therapeutic target for hepatocellular carcinoma: Experimental and clinical scenarios.

Authors:  Swati Katoch; Vinesh Sharma; Vikram Patial
Journal:  World J Gastroenterol       Date:  2022-07-28       Impact factor: 5.374

7.  Identification of Warning Transition Points from Hepatitis B to Hepatocellular Carcinoma Based on Mutation Accumulation for the Early Diagnosis and Potential Drug Treatment of HBV-HCC.

Authors:  Fei Xu; Qingkang Meng; Feng Wu; Yakun Wang; Wenjun Yang; Yun Tong; Lei Liu; Xiujie Chen
Journal:  Oxid Med Cell Longev       Date:  2022-09-05       Impact factor: 7.310

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.